Identification of shared risk loci and pathways for bipolar disorder and schizophrenia

PLoS ONE

Volumn 12, Issue 2, 2017, Pages

  Forstner, Andreas J ^a,b,c,d   Hecker, Julian ^a   Hofmann, Andrea ^a   Maaser, Anna ^a   Reinbold, Céline S ^c,d   Mühleisen, Thomas W ^a,c,d,e   Leber, Markus ^f   Strohmaier, Jana ^g   Degenhardt, Franziska ^a   Treutlein, Jens ^g   Mattheisen, Manuel ^a,h,i   Schumacher, Johannes ^a   Streit, Fabian ^g   Meier, Sandra ^g,h,i   Herms, Stefan ^a,d,s   Hoffmann, Per ^a,c,d   Lacour, André ^j   Witt, Stephanie H ^g   Reif, Andreas ^k   Müller Myhsok, Bertram ^l,m,n   Lucae, Susanne ^l   Maier, Wolfgang ^a   Schwarz, Markus ^o   Vedder, Helmut ^o   Kammerer Ciernioch, Jutta ^p   Pfennig, Andrea ^q   Bauer, Michael ^q   Hautzinger, Martin ^r   Moebus, Susanne ^s   Schenk, Lorena M ^a   Fischer, Sascha B ^c,d   Sivalingam, Sugirthan ^a   Czerski, Piotr M ^t   Hauser, Joanna ^t   Lissowska, Jolanta ^u   Szeszenia Dabrowska, Neonila ^v   Brennan, Paul ^w   McKay, James D ^w   Wright, Adam ^x,y   Mitchell, Philip B ^x,y   Fullerton, Janice M ^x,z   Schofield, Peter R ^x,z   Montgomery, Grant W ^aa   Medland, Sarah E ^aa   Gordon, Scott D ^aa   Martin, Nicholas G ^aa   Krasnov, Valery ^ab   Chuchalin, Alexander ^ac   Babadjanova, Gulja ^ac   Pantelejeva, Galina ^ad   Abramova, Lilia I ^ad   Tiganov, Alexander S ^ad   Polonikov, Alexey ^ae   Khusnutdinova, Elza ^af,ag   Alda, Martin ^ag,ah,ai   Cruceanu, Cristiana ^aj,ak,al   Rouleau, Guy A ^aj   Turecki, Gustavo ^ak,al   Laprise, Catherine ^am   Rivas, Fabio ^an   Mayoral, Fermin ^an   Kogevinas, Manolis ^ao   Grigoroiu Serbanescu, Maria ^ap   Becker, Tim ^a,j,ap   Schulze, Thomas G ^aq   Rietschel, Marcella ^g   Cichon, Sven ^a,c,d,e   Fier, Heide ^a   Nöthen, Markus M ^a   more..

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e FORSCHUNGSZENTRUM JÜLICH   (Germany)

^f UNIVERSITY OF COLOGNE   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h AARHUS UNIVERSITY   (Denmark)

ⁱ H LUNDBECK A S   (Denmark)

^j GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^k UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^l MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^m Technische Universität München Munich Cluster for Systems Neurology   (Germany)

ⁿ UNIVERSITY OF LIVERPOOL   (United Kingdom)

^o Psychiatric Center Nordbaden   (Germany)

^p Center of Psychiatry Weinsberg   (Germany)

^q UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^r UNIVERSITY OF TÜBINGEN   (Germany)

^s UNIVERSITY OF DUISBURG ESSEN   (Germany)

^t POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^u INSTITUTE OF ONCOLOGY   (Poland)

^v NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^w INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^x UNIVERSITY OF NEW SOUTH WALES   (Australia)

^y PRINCE OF WALES HOSPITAL   (Australia)

^z NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^aa QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^ab Moscow Research Institute of Psychiatry   (Russian Federation)

^ac PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^ad MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^ae KURSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^af INSTITUTE OF BIOCHEMISTRY AND GENETICS   (Russian Federation)

^ag Science and Education Center of Bashkir People History Ufa University of Science and Technology   (Russian Federation)

^ah DALHOUSIE UNIVERSITY   (Canada)

^ai NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^aj MCGILL UNIVERSITY   (Canada)

^ak MCGILL UNIVERSITY   (Canada)

^al MCGILL UNIVERSITY   (Canada)

^am UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

^an HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^ao CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^ap Psychiatric Hospital Bucharest   (Romania)

^aq LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALMODULIN; GLUTAMIC ACID;

ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOME-WIDE ASSOCIATION STUDY; HUMAN; MAJOR CLINICAL STUDY; NEUROPATHIC PAIN; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANK1 GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; QUANTITATIVE TRAIT LOCUS; RISK;

BIPOLAR DISORDER; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RISK; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 85011636383     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0171595     Document Type: Article

References (46)

1. Craddock N, Sklar P. Genetics of bipolar disorder. Lancet. 2013; 381(9878):1654-62. doi: 10.1016/ S0140-6736(13)60855-7 PMID: 23663951
2. Nothen MM, Nieratschker V, Cichon S, Rietschel M. New findings in the genetics of major psychoses. Dialogues Clin Neurosci. 2010; 12(1):85-93. PMID: 20373670
3. Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013; 45(9):984-94. doi: 10. 1038/ng.2711 PMID: 23933821
4. Ruderfer DM, Fanous AH, Ripke S, McQuillin A, Amdur RL, Gejman PV, et al. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol Psychiatry. 2014; 19 (9):1017-24. doi: 10.1038/mp.2013.138 PMID: 24280982
5. Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet. 2011; 43 (10):977-83. doi: 10.1038/ng.943 PMID: 21926972
6. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry. 2008; 13(2):197-207. doi: 10.1038/sj.mp.4002012 PMID: 17486107
7. Chen DT, Jiang X, Akula N, Shugart YY, Wendland JR, Steele CJ, et al. Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry. 2013; 18(2):195-205. doi: 10.1038/mp.2011.157 PMID: 22182935
8. Cichon S, Muhleisen TW, Degenhardt FA, Mattheisen M, Miro X, Strohmaier J, et al. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet. 2011; 88(3):372-81. doi: 10.1016/j.ajhg.2011.01.017 PMID: 21353194
9. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, et al. Collaborative genomewide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. 2008; 40(9):1056-8. doi: 10.1038/ng.209 PMID: 18711365
10. Green EK, Grozeva D, Forty L, Gordon-Smith K, Russell E, Farmer A, et al. Association at SYNE1 in both bipolar disorder and recurrent major depression. Mol Psychiatry. 2013; 18(5):614-7. doi: 10.1038/ mp.2012.48 PMID: 22565781
11. Green EK, Hamshere M, Forty L, Gordon-Smith K, Fraser C, Russell E, et al. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample. Mol Psychiatry. 2013; 18(12):1302-7. doi: 10.1038/mp.2012.142 PMID: 23070075
12. Muhleisen TW, Leber M, Schulze TG, Strohmaier J, Degenhardt F, Treutlein J, et al. Genome-wide association study reveals two new risk loci for bipolar disorder. Nat Commun. 2014; 5:3339. doi: 10. 1038/ncomms4339 PMID: 24618891
13. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet. 2012; 13(8):537-51. doi: 10.1038/nrg3240 PMID: 22777127
14. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014; 511(7510):421-7. doi: 10.1038/nature13595 PMID: 25056061
15. Pasaniuc B, Zaitlen N, Shi H, Bhatia G, Gusev A, Pickrell J, et al. Fast and accurate imputation of summary statistics enhances evidence of functional enrichment. Bioinformatics. 2014; 30(20):2906-14. doi: 10.1093/bioinformatics/btu416 PMID: 24990607
16. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010; 26(17):2190-1. doi: 10.1093/bioinformatics/btq340 PMID: 20616382
17. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013; 381(9875):1371-9. doi: 10.1016/S0140-6736(12)62129-1 PMID: 23453885
18. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study identifies five new schizophrenia loci. Nat Genet. 2011; 43(10):969-76. doi: 10.1038/ng. 940 PMID: 21926974
19. Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh PR, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015; 47(11):1236-41. doi: 10.1038/ng.3406 PMID: 26414676
20. Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F, et al. Integrating common and rare genetic variation in diverse human populations. Nature. 2010; 467(7311):52-8. doi: 10.1038/ nature09298 PMID: 20811451
21. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics. 2008; 24(24):2938-9. doi: 10.1093/bioinformatics/btn564 PMID: 18974171
22. Fillman SG, Cloonan N, Catts VS, Miller LC, Wong J, McCrossin T, et al. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry. 2013; 18(2):206-14. doi: 10.1038/mp.2012.110 PMID: 22869038
23. Winham SJ, Cuellar-Barboza AB, McElroy SL, Oliveros A, Crow S, Colby CL, et al. Bipolar disorder with comorbid binge eating history: a genome-wide association study implicates APOB. J Affect Disord. 2014; 165:151-8. doi: 10.1016/j.jad.2014.04.026 PMID: 24882193
24. Lee PH, O'Dushlaine C, Thomas B, Purcell SM. INRICH: interval-based enrichment analysis for genome-wide association studies. Bioinformatics. 2012; 28(13):1797-9. doi: 10.1093/bioinformatics/ bts191 PMID: 22513993
25. Nurnberger JI Jr., Koller DL, Jung J, Edenberg HJ, Foroud T, Guella I, et al. Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry. 2014; 71(6):657-64. doi: 10.1001/ jamapsychiatry.2014.176 PMID: 24718920
26. Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kahler AK, Akterin S, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013; 45(10):1150-9. doi: 10.1038/ng. 2742 PMID: 23974872
27. Xu W, Cohen-Woods S, Chen Q, Noor A, Knight J, Hosang G, et al. Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1. BMC Med Genet. 2014; 15:2. doi: 10.1186/1471-2350-15-2 PMID: 24387768
28. Harrison PJ. Molecular neurobiological clues to the pathogenesis of bipolar disorder. Curr Opin Neurobiol. 2016; 36:1-6. doi: 10.1016/j.conb.2015.07.002 PMID: 26210959
29. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009; 373(9659):234-9. doi: 10.1016/S0140-6736(09)60072-6 PMID: 19150704
30. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009; 460(7256):748-52. doi: 10.1038/nature08185 PMID: 19571811
31. Hannon E, Spiers H, Viana J, Pidsley R, Burrage J, Murphy TM, et al. Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci. Nat Neurosci. 2016; 19(1):48-54. doi: 10.1038/ nn.4182 PMID: 26619357
32. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, Beazley C, et al. Population genomics of human gene expression. Nat Genet. 2007; 39(10):1217-24. doi: 10.1038/ng2142 PMID: 17873874
33. Ohi K, Shimada T, Nitta Y, Kihara H, Okubo H, Uehara T, et al. Schizophrenia risk variants in ITIH4 and CALN1 regulate gene expression in the dorsolateral prefrontal cortex. Psychiatr Genet. 2016; 26 (3):142-3. doi: 10.1097/YPG.0000000000000127 PMID: 26991396
34. Gyorgy AB, Szemes M, de Juan Romero C, Tarabykin V, Agoston DV. SATB2 interacts with chromatinremodeling molecules in differentiating cortical neurons. Eur J Neurosci. 2008; 27(4):865-73. doi: 10. 1111/j.1460-9568.2008.06061.x PMID: 18333962
35. Alcamo EA, Chirivella L, Dautzenberg M, Dobreva G, Farinas I, Grosschedl R, et al. Satb2 regulates callosal projection neuron identity in the developing cerebral cortex. Neuron. 2008; 57(3):364-77. doi: 10.1016/j.neuron.2007.12.012 PMID: 18255030
36. Rosenfeld JA, Ballif BC, Lucas A, Spence EJ, Powell C, Aylsworth AS, et al. Small deletions of SATB2 cause some of the clinical features of the 2q33.1 microdeletion syndrome. PLoS One. 2009; 4(8): e6568. doi: 10.1371/journal.pone.0006568 PMID: 19668335
37. Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang C, Heilbut A, et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell. 2012; 149(3):525-37. doi: 10.1016/j.cell.2012.03.028 PMID: 22521361
38. Tarabeux J, Kebir O, Gauthier J, Hamdan FF, Xiong L, Piton A, et al. Rare mutations in N-methyl-Daspartate glutamate receptors in autism spectrum disorders and schizophrenia. Transl Psychiatry. 2011; 1:e55. doi: 10.1038/tp.2011.52 PMID: 22833210
39. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. doi: 10.1038/75556PMID: 10802651
40. Shim SS, Hammonds MD, Tatsuoka C, Feng IJ. Effects of 4-weeks of treatment with lithium and olanzapine on long-term potentiation in hippocampal area CA1. Neurosci Lett. 2012; 524(1):5-9. doi: 10.1016/ j.neulet.2012.06.047 PMID: 22750162
41. Goto Y, Yang CR, Otani S. Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders. Biol Psychiatry. 2010; 67(3):199-207. doi: 10.1016/j.biopsych.2009.08.026 PMID: 19833323
42. Salavati B, Rajji TK, Price R, Sun Y, Graff-Guerrero A, Daskalakis ZJ. Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation. Schizophr Bull. 2015; 41(1):44-56. doi: 10.1093/schbul/sbu132 PMID: 25249654
43. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genomewide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci. 2015; 18(2):199-209. doi: 10.1038/nn.3922 PMID: 25599223
44. Cherlyn SY, Woon PS, Liu JJ, Ong WY, Tsai GC, Sim K. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance. Neurosci Biobehav Rev. 2010; 34(6):958-77. doi: 10.1016/j.neubiorev.2010.01.002 PMID: 20060416
45. Muhleisen TW, Mattheisen M, Strohmaier J, Degenhardt F, Priebe L, Schultz CC, et al. Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder. Schizophr Res. 2012; 138(1):69-73. doi: 10.1016/j.schres.2012.03.007 PMID: 22497794
46. Miro X, Meier S, Dreisow ML, Frank J, Strohmaier J, Breuer R, et al. Studies in humans and mice implicate neurocan in the etiology of mania. Am J Psychiatry. 2012; 169(9):982-90. doi: 10.1176/appi.ajp. 2012.11101585 PMID: 22952076